Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-induced fatty liver disease: An overview of pathogenesis and management.

Annals of hepatology - 1 Jan 2000

Satapathy Sanjaya K, Kuwajima Vanessa, Nadelson Jeffrey, Atiq Omair, Sanyal Arun J

Abstract excerpt

Over the past decades, many drugs have been identified, that can potentially induce steatohepatitis in the predisposed individual. Classically this has been incriminated to amiodarone, perhexiline, and 4,4'-diethylaminoethoxyhexestrol (DH), all of which have been found to independently induce the histologic picture of non-alcoholic steatohepatitis (NASH). Pathogenetic mechanisms of hepatotoxicity although still...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Triphosphate
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Energy Metabolism

Share to Fatty Acids

Share to Mitochondria, Liver

Share to Non-alcoholic Fatty Liver Disease

Share to Predictive Value of Tests

Source

Identifiers

PMID: 26436351
DOI: 10.5604/16652681.1171749

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-induced fatty liver disease: An overview of pathogenesis and management.PMID 26436351Read ↗

Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes.Semantic proximity Read ↗

Present and future therapeutic strategies in non-alcoholic fatty liver disease.Semantic proximity Read ↗

Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs.Semantic proximity Read ↗

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read ↗

[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies].Semantic proximity Read ↗

The Interplay between Endocrine-Disrupting Chemicals and the Epigenome towards Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive ReviewSemantic proximity Read ↗

Chronic liver injury induced by drugs and toxins.Semantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Drug-induced liver injury in older people.Semantic proximity Read ↗

Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Semantic proximity Read ↗

Pharmaceutical Strategies to Make Better Drugs for Nonalcoholic Fatty Liver Disease TherapySemantic proximity Read ↗

Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.